Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:42 AM ET 8-K
Contract Win Cycurion, Inc. CYCU

Cycurion Wins $54.6M Contract from global consulting firm

Cycurion announced a $54.6 million, 10-year contract to modernize and securely operate a major state Health and Human Services system. The contract, which is the largest in the company's history, is expected to generate over $5 million in annual recurring revenue with work commencing in November 2026.

Value
$54.6M
Counterparty
global consulting firm
Term
10 years
7:01 AM ET 8-K
Clinical Trial Data Fractyl Health, Inc. GUTS

Fractyl Health Clinical Trial Data

Fractyl Health announced positive topline six-month results from its REMAIN-1 Pivotal Cohort study evaluating the Revita DMR System for weight maintenance after GLP-1 therapy discontinuation. The study met its six-month co-primary endpoint with high statistical significance (p=0.0023), showing that Revita participants retained 80% of their weight loss compared to 67% for the sham group. The company plans to submit a De Novo marketing application to the FDA in late Q4 2026 based on these results.

7:01 AM ET 8-K
Licensing Deal RYTHM, Inc. RYM

RYTHM Licensing Deal with GTI Core, LLC

RYTHM, Inc.'s subsidiary VCP IP Holdings amended its licensing agreement with Green Thumb Industries' subsidiary GTI Core to add the Señorita brand to the licensed intellectual property. In exchange for the additional rights, the base licensing fees paid to RYTHM will increase by $250,000 per year.

Counterparty
GTI Core, LLC
6:04 AM ET 8-K
M&A Deal International Seaways, Inc. INSW

International Seaways Signs $370M M&A Deal with Bruton Limited

International Seaways (INSW) entered into a definitive agreement to acquire Bruton Limited in a transaction valuing the target at approximately $370 million. The deal involves a two-step process: an immediate exchange for 50.5% of Bruton's shares followed by a merger for the remaining shares, primarily using INSW common stock at an exchange ratio of 0.05190 per Bruton share.

Value
$370M
Counterparty
Bruton Limited

“We're excited about the opportunity to expand and modernize our fleet through this accretive transaction with Bruton. The transaction underscores our disciplined approach to growth. Following completion of the transaction, Seaways will remain well-positioned to continue executing on our growth strategy, generating attractive returns and creating long-term value for our shareholders.”

Lois K. Zabrocky, International Seaways President and CEO
6:04 AM ET 8-K/A
M&A Deal Ensysce Biosciences, Inc. ENSC

Ensysce Biosciences M&A Deal with Cy Biopharma, Inc.

Ensysce Biosciences completed the acquisition of Cy Biopharma, Inc. on August 5, 2026, through a two-step merger process. As consideration, Ensysce issued 282,122 shares of Series C Preferred Stock to Cy Biopharma equityholders, with each share convertible into 1,000 shares of common stock. This filing (Amendment No. 2) provides required historical and pro forma financial statements related to the transaction.

Counterparty
Cy Biopharma, Inc.
6:02 AM ET 8-K
M&A Deal Skydance Corp SKYD

Skydance M&A Deal with Warner Bros. Discovery, Inc.

Skydance Corporation completed its merger with Warner Bros. Discovery, Inc. on October 6, 2026, and subsequently distributed 470,746,773 warrants to Class B stockholders as a dividend. The filing also provides a status update regarding a temporary trading blackout period for the company's 401(k) plan and executive officers to facilitate the conversion of plan assets following the merger.

Counterparty
Warner Bros. Discovery, Inc.
6:00 AM ET 8-K
Bankruptcy & Restructuring Sangamo Therapeutics, Inc SGMOQ

Sangamo Therapeutics Bankruptcy & Restructuring

Sangamo Therapeutics, Inc. filed a monthly operating report (MOR) for August 2026 as part of its ongoing Chapter 11 bankruptcy proceedings in the District of Delaware. The report discloses a month-end cash balance of $23.2 million and total liabilities of $107.3 million. Additionally, the company's common stock is being delisted from Nasdaq effective October 17, 2026, following its suspension in May 2026.

5:25 PM ET 8-K
M&A Deal FG Communities Holdings Inc. FGC

FG Communities Holdings M&A Deal with unaffiliated third party

FG Communities Holdings Inc. completed the acquisition of two manufactured housing communities in North Carolina, located in Garner and Mars Hill. The acquisitions added a combined 78 homesites across 78 acres to the company's portfolio and were funded using cash on hand.

Counterparty
unaffiliated third party
5:23 PM ET 8-K
Clinical Trial Data Opus Genetics, Inc. IRD

Opus Genetics Clinical Trial Data

Opus Genetics presented positive clinical data from its OPGx-BEST1 and OPGx-LCA5 gene therapy programs at the Retina in Rio 2026 conference. OPGx-BEST1 showed improved retinal sensitivity in 75% of Cohort 1 participants, while OPGx-LCA5 demonstrated sustained visual improvements through 24 months in adults and 6 months in pediatric patients.

5:21 PM ET 8-K
M&A Deal Varonis Systems Inc VRNS

Varonis Systems Signs $6.3B M&A Deal with Proofpoint, Inc.

Varonis Systems has entered into a definitive agreement to be acquired by Proofpoint, Inc., a portfolio company of Thoma Bravo, in an all-cash transaction valued at approximately $6.3 billion. Varonis shareholders will receive $49.75 per share in cash, representing a 52% premium to the company's unaffected stock price. The deal is expected to close in the first half of 2027 and will create a unified cybersecurity platform focused on data and AI security.

Value
$6.3B
Counterparty
Proofpoint, Inc.
Term
through first half of 2027
5:19 PM ET 8-K
Licensing Deal Biohaven Ltd. BHVN

Biohaven Licensing Deal with Ono Pharmaceutical Co., Ltd. Worth $100M

Biohaven granted Ono Pharmaceutical an exclusive license to develop and commercialize its MoDE pan IgG degrader portfolio, including lead candidate BHV-1300, in Japan, South Korea, Taiwan, and ASEAN countries. Biohaven receives an $80 million upfront payment and is eligible for a $20 million milestone payment plus royalties of approximately 20% on net sales in the territory.

Value
$100M
Counterparty
Ono Pharmaceutical Co., Ltd.
5:16 PM ET 8-K
M&A Deal SPACSphere Acquisition Corp. SSAC

SPACSphere Acquisition M&A Deal with Mobilewalla Holdco, Inc.

SPACSphere Acquisition Corp. entered into an amendment to its existing business combination agreement with Mobilewalla Holdco, Inc. to increase the size of the post-merger board of directors from five to seven members. The amendment also specifies the initial director designees for the combined company, which will be renamed Covariate, Inc. upon the closing of the transaction.

Counterparty
Mobilewalla Holdco, Inc.
5:01 PM ET 8-K
Capital Raise Pine Tree Acquisition Corp. PAXG

Pine Tree Acquisition Capital Raise of $6M

Pine Tree Acquisition Corp. consummated the sale of 600,000 additional units at $10.00 per unit following the partial exercise of the underwriter's over-allotment option. The transaction generated $6 million in gross proceeds, bringing the total amount held in the company's trust account to $106 million.

Value
$6M
Counterparty
Maxim Group LLC
4:37 PM ET 8-K
Capital Raise Blackstone Real Estate Income Trust, Inc. BSTT

Blackstone Real Estate Income Trust Capital Raise of $10.3M

Blackstone Real Estate Income Trust, Inc. sold unregistered shares of its Class C common stock to investment vehicles for aggregate consideration of approximately $10.3 million. The sales occurred in two tranches on September 1 and October 1, 2026, and were conducted as private placements exempt from registration under Section 4(a)(2) and Regulation S.

Value
$10.3M
Counterparty
certain investment vehicles
4:35 PM ET 8-K
Capital Raise Crypto Co CRCW

Crypto Capital Raise

The Crypto Company entered into subscription agreements to raise $75,000 through a private placement of 97,165,533 shares of common stock. The consideration consisted of $65,000 in cash and 3.4683 ETH, with one of the investors being an entity managed by the company's Chief Strategy Officer.

Counterparty
James Smittkamp and Three Mile Creek Future LLC
4:31 PM ET 8-K
Bankruptcy & Restructuring Greenlane Holdings, Inc. GNLN

Greenlane Holdings Bankruptcy & Restructuring

Greenlane Holdings' subsidiaries filed petitions in the Florida Circuit Court to commence assignment proceedings for the benefit of creditors. The court has assumed jurisdiction over the assets of Warehouse Goods LLC, Greenlane Holdings LLC, KIM International LLC, and Kush Supply Co. LLC, which will be liquidated by an assignee to pay creditors.

Counterparty
Philip J. von Kahle
4:29 PM ET 8-K
Capital Raise First Tracks Biotherapeutics, Inc. TRAX

First Tracks Biotherapeutics Capital Raise of $200M

First Tracks Biotherapeutics entered into a securities purchase agreement for a $200 million private placement (PIPE) of 6,106,870 shares of common stock at $32.75 per share. The offering includes participation from several institutional investors and is intended to fund the clinical development of ANB033 and other general corporate purposes.

Value
$200M
Counterparty
Affinity Asset Advisors, LLC, First Light Asset Management, Sirenia Capital Management LP, TCGX, Trails Edge Capital Partners, Vestal Point Capital
4:25 PM ET 8-K
M&A Deal Daily Journal Corp DJCO

Daily Journal M&A Deal with Revir Technologies, Inc.

Daily Journal Corporation completed the acquisition of Austin-based software company Revir Technologies, Inc. on October 13, 2026. Revir, which provides the Scout AI-powered digital evidence management platform for law enforcement and public safety agencies, will operate independently within Daily Journal's Courts, Justice, and Government Technology division.

Counterparty
Revir Technologies, Inc.
4:24 PM ET 8-K
Capital Raise Frazier Life Sciences Acquisition Corp. II FLSC

Frazier Life Sciences Acquisition Corp. II Capital Raise of $78M

Frazier Life Sciences Acquisition Corp. II consummated its initial public offering (IPO) of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds. Simultaneously, the company's sponsor purchased 300,000 private placement shares for an additional $3 million, and a forward purchase agreement was established for at least $25 million to be funded at the time of a future business combination.

Value
$78M
Counterparty
Jefferies LLC
4:18 PM ET 8-K
M&A Deal Indivior Pharmaceuticals, Inc. SUPN

Indivior Pharmaceuticals M&A Deal Update

Stockholders of Indivior Pharmaceuticals, Inc. approved the issuance of common stock in connection with a previously announced merger agreement. The vote satisfies Nasdaq Rule 5635 requirements for the share issuance, marking a key step toward completing the acquisition.

4:17 PM ET 8-K
Nasdaq/NYSE Compliance Notice Cyngn Inc. CYN

Cyngn Nasdaq/NYSE Compliance Notice

Cyngn Inc. received a deficiency notice from Nasdaq on October 14, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has 180 calendar days, or until April 12, 2027, to regain compliance by maintaining a bid price of at least $1.00 for at least 10 consecutive business days.

Counterparty
Nasdaq
Term
180 days
4:16 PM ET 8-K
Divestiture Fortune Brands Innovations, Inc. FBIN

Fortune Brands Innovations Divestiture to Inteplast Group Corporation for $160M

Fortune Brands Innovations has entered into a definitive agreement to sell its Fiberon composite decking business to a subsidiary of Inteplast Group Corporation for $160 million in cash. In connection with the sale, the company expects to record a non-cash impairment charge between $175 million and $205 million. The divestiture is part of a strategic review to focus resources on higher-return opportunities and is expected to close within 60 days.

Value
$160M
Counterparty
Inteplast Group Corporation
4:16 PM ET 8-K
M&A Deal Sow Good Inc. SOWG

Sow Good M&A Deal with Ryzon Materials Limited

Sow Good Inc. and its subsidiary entered into an extension letter to a previously announced Share Purchase Agreement with Ryzon Materials Limited and other sellers. The letter extends the 'Sunset Date' for the acquisition to October 30, 2026. This filing provides a timeline update on a pending merger/acquisition transaction.

Counterparty
Ryzon Materials Limited
4:15 PM ET 8-K
M&A Deal Colony Bankcorp Inc CBAN

Colony Bankcorp Signs $163M M&A Deal with First Reliance Bancshares, Inc.

Colony Bankcorp shareholders approved the issuance of common stock for the acquisition of First Reliance Bancshares, Inc. in a stock-and-cash transaction valued at approximately $163 million. The deal has received all necessary regulatory approvals and is expected to close in the fourth quarter of 2026, creating a combined entity with approximately $5 billion in total assets.

Value
$163M
Counterparty
First Reliance Bancshares, Inc.
4:11 PM ET 8-K
M&A Deal Supernus Pharmaceuticals, Inc. SUPN

Supernus Pharmaceuticals M&A Deal with Indivior Pharmaceuticals Inc.

Supernus Pharmaceuticals stockholders approved the company's acquisition by Indivior Pharmaceuticals at a special meeting held on October 15, 2026. Under the terms of the merger agreement, Supernus will become a wholly-owned subsidiary of Indivior. Stockholders also approved, on a non-binding basis, the merger-related compensation for the company's named executive officers.

Counterparty
Indivior Pharmaceuticals Inc.
4:10 PM ET 8-K
M&A Deal Melar Acquisition Corp. I MACI

Melar Acquisition Corp. I M&A Deal with Everli Global Inc.

Melar Acquisition Corp. I provided a status update on its pending business combination with Everli Global Inc., an Italian e-grocery marketplace. The filing includes a press release from Everli outlining its asset-light business model and retail network, which includes partnerships with Italy's 13 largest grocers. Upon closing, the combined company is expected to trade on Nasdaq under the ticker EVRL.

Counterparty
Everli Global Inc.
4:08 PM ET 8-K
Divestiture Opko Health, Inc. OPK

Opko Health Divestiture to Laboratory Corporation of America Holdings for $722M

OPKO Health and its subsidiary BioReference Health entered into a definitive agreement to sell certain assets of their clinical and anatomic pathology laboratory testing business to Labcorp for $722 million in cash. The deal includes clinical and women’s health testing, urology, and the proprietary 4Kscore prostate cancer test, with OPKO eligible for up to an additional $150 million in milestone payments over ten years based on 4Kscore revenue. The transaction is subject to HSR Clearance and customary closing conditions, with a target completion date by April 14, 2027.

Value
$722M
Counterparty
Laboratory Corporation of America Holdings
Term
up to 10 years
4:06 PM ET 8-K
Nasdaq/NYSE Compliance Notice Innovative Eyewear Inc LUCY

Innovative Eyewear Nasdaq/NYSE Compliance Notice

Innovative Eyewear received a deficiency notice from Nasdaq on October 9, 2026, because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until April 7, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.

Counterparty
The Nasdaq Stock Market LLC
Term
180 days
4:06 PM ET 8-K/A
Divestiture Faraday Future Intelligent Electric Inc. FFAI

Faraday Future Intelligent Electric Divestiture to FF EAI Robotics Ecosystem Inc. for $200M

Faraday Future Intelligent Electric Inc. (FFAI) entered into a definitive agreement to sell its robotics business to FF EAI Robotics Ecosystem Inc. (FFR) for approximately $200 million in an all-stock transaction. FFAI will receive FFR common and preferred stock at a price of $2.246 per share, resulting in FFAI becoming the majority and controlling stockholder of FFR with a 65.7% stake.

Value
$200M
Counterparty
FF EAI Robotics Ecosystem Inc. (FFR)
4:06 PM ET 8-K
Contract Win Consolidated Water Co. Ltd. CWCO

Consolidated Water Co Wins $39.8M Contract from City of Pismo Beach, California

Consolidated Water's subsidiary, PERC Water Corporation, entered into a $39.8 million design-build agreement with the City of Pismo Beach for the Central Coast Blue Advanced Water Purification Facility. The project involves designing and constructing a drought-resistant water supply system using ultrafiltration and reverse osmosis, with substantial completion expected by September 2028.

Value
$39.8M
Counterparty
City of Pismo Beach, California
Term
703 calendar days

“This award reflects the strength of our advanced water-treatment capabilities and our ability to compete successfully for technically sophisticated design-build projects. We are proud that PERC Water was selected following a rigorous competitive evaluation, and we look forward to supporting the City of Pismo Beach as it advances a reliable, locally controlled, and drought-resistant water supply.”

Rick McTaggart, Consolidated Water CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.